论著

血清维生素D水平对老年慢性肾脏病患者肾功能的影响

展开
  • a.上海交通大学医学院附属瑞金医院 老年科,上海 200025
    b.上海交通大学医学院附属瑞金医院 肾脏科,上海 200025
    c.上海交通大学医学院附属瑞金医院 检验科,上海 200025

收稿日期: 2022-01-27

  网络出版日期: 2022-08-08

Effect of serum vitamin D level on renal function in elderly patients with chronic kidney disease

Expand
  • a. Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    b. Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    c. Department of Clinical Laboratory, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2022-01-27

  Online published: 2022-08-08

摘要

目的: 探讨血清维生素D水平对老年慢性肾脏病(chronic kidney disease, CKD)患者肾功能的影响。方法: 收集2014年1月至2019年5月在上海交通大学医学院附属瑞金医院肾脏科和老年科诊治的年龄≥60岁CKD 1~4期患者的临床及随访资料。采用化学发光法测定血清25羟维生素D[25(OH) D ]水平,按25(OH)D水平将患者分为维生素D缺乏组 [25(OH)D<50 nmol/L] 及不缺乏组 [包括充足及不足,即25(OH)D≥50 nmol/L]。比较2组患者基线临床及预后指标。结果: 共纳入347例老年CKD患者,与CKD1~2期患者相比,CKD 3期及以上患者的维生素D水平显著降低。维生素D缺乏发生率在CKD 1~2期和CKD 3期及以上患者的发生率分别为46.7%、67.6%。在CKD 3期及以上患者中,与维生素D不缺乏组相比,维生素D缺乏组患者甲状旁腺素、血尿酸及血肌酐水平较高,而血钙及估算的肾小球滤过率(estimated glomerular filtration rate,eGFR)较低,且维生素D缺乏组较不缺乏组发生eGFR下降≥30%或出现终末期肾脏病的比例较高(16.9%比2.9%,P=0.042)。多因素Logistic回归分析显示,维生素D缺乏独立于男性、年龄大、高平均动脉压、低血红蛋白、低白蛋白、高蛋白尿及高尿酸,为发生3期及以上CKD的独立风险因素。结论: 在老年CKD 3~4期患者中,维生素D缺乏组患者的eGFR显著下降,且维生素D缺乏是发生3期及以上CKD进展的独立危险因素。

本文引用格式

章晓炎, 徐静, 璩斌 . 血清维生素D水平对老年慢性肾脏病患者肾功能的影响[J]. 内科理论与实践, 2022 , 17(04) : 307 -312 . DOI: 10.16138/j.1673-6087.2022.04.007

Abstract

Objective To investigate the association between vitamin D and chronic kidney disease (CKD) in elderly patients. Methods The clinical and follow-up data of elderly patients aged≥60 years diagnosed with CKD at stage 1-4 were collected in the Department of Nephrology and Department of Geriatrics of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from January 2014 to May 2019. The serum 25-hydroxy vitamin D[25(OH)D] level was detected using photochemical method. All patients were divided into vitamin D deficiency group [25(OH)D<50 nmol/L] and non-deficiency group [including sufficient and insufficient levels of 25(OH)D, namely 25(OH)D≥50 nmol/L] according to 25(OH)D level. The baseline clinical and prognostic indicators were compared between two groups. Results Totally 347 elderly CKD patients were enrolled in this study. Compared to the patients with stage 1-2 CKD, the vitamin D level in those with stage 3-4 CKD was significantly lower. The incidence of vitamin D deficiency in the patients with stage 1-2 CKD and stage 3-4 CKD was 46.7% and 67.6%, respectively. Compared with the patients without vitamin D deficiency at stage 3-4 CKD, the patients with vitamin D deficiency at same stage had higher parathyroid hormone, serum uric acid, serum creatinine and rate of estimated glomerular filtration rate(eGFR) decline of at least 30% or progression into end-stage renal disease (16.9% vs 2.9%, P=0.042), and lower serum calcium and eGFR. The multivariate Logistic regression analysis showed that the vitamin D deficiency was an independent risk factor for the patients with stage 3-4 CKD after adjusting gender, age, mean arterial pressure, hemoglobin, albumin, proteinuria, and uric acid. Conclusions The patients with vitamin D deficiency at stages 3-4 CKD had significantly lower eGFR. The vitamin D deficiency is an independent risk factor for onset of CKD at stages 3-4.

参考文献

[1] Michener KH, Mitchell GF, Noubary F, et al. Aortic stiffness and kidney disease in an elderly population[J]. Am J Nephrol, 2015, 41(4-5): 320-328.
[2] Hruska KA, Sugatani T, Agapova O, et al. The chronic kidney disease - mineral bone disorder (CKD-MBD): advances in pathophysiology[J]. Bone, 2017, 100: 80-86.
[3] ANON. Kidney disease: improving global outcomes CKDMBDUWG, KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder(CKD-MBD)[J]. Kidney Int Suppl(2011), 2017, 7(1):1-59.
[4] Boucher BJ. The problems of vitamin d insufficiency in older people[J]. Aging Dis, 2012, 3(4): 313-329.
[5] Berridge MJ. Vitamin D deficiency and diabetes[J]. Biochem J, 2017, 474(8): 1321-1332.
[6] Jeong HY, Park KM, Lee MJ, et al. Vitamin D and hypertension[J]. Electrolyte Blood Press, 2017. 15(1): 1-11.
[7] Kiss I, Kiss Z, Ambrus C, et al. Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in hungary—results from a nationwide clinical audit[J]. BMC Nephrol, 2013, 14: 155.
[8] Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patient[J]. Kidney Int, 2012, 82(8): 840-856.
[9] Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612.
[10] 中国医师协会肾脏内科医师分会维生素D实践方案专家协作组. 维生素D及其类似物在慢性肾脏病患者中应用的中国实践方案(2019版)[J]. 中华内科杂志, 2020, 59(2): 104-116.
[11] Franca Gois PH, Wolley M, Ranganathan D, et al. Vitamin D deficiency in chronic kidney disease: recent evidence and controversies[J]. Int J Environ Res Public Health, 2018, 15(8): 1773.
[12] Morrone LF, Bolasco P, Camerini C, et al. Vitamin D in patients with chronic kidney disease: a position statement of the Working Group“Trace Elements and Mineral Metabolism” of the Italian Society of Nephrology[J]. J Nephrol, 2016, 29(3): 305-328.
[13] LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States[J]. Am J Kidney Dis, 2005, 45(6): 1026-1033.
[14] Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease[J]. Kidney Int, 2009, 75(1): 88-95.
[15] Satirapoj B, Limwannata P, Chaiprasert A, et al. Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population[J]. BMC Nephrol, 2013, 14: 206.
[16] Tapper M, McGrowder DA, Dilworth L, et al. Cystatin C, vitamin D and thyroid function test profile in chronic kidney disease patients[J]. Diseases, 2021, 9(1): 5.
[17] Ghosh SK, Ghosh S. Cross-sectional study on vitamin D status in CKD patients[J]. J Assoc Physicians India, 2020, 68(4): 26-28.
[18] 吕轶伦, 林颍, 史浩, 等. 慢性肾脏病患者维生素D不足与缺乏[J]. 中华肾脏病杂志, 2009, 25(9): 668-672.
[19] Sah SK, Adhikary LP. Prevalence of abnormal serum 25-hydroxyvitamin D and its association with hemoglobin level in pre dialysis CKD patients: a cross-sectional study from Himalayan country[J]. BMC Nephrol, 2019, 20(1): 267.
[20] Wang Y, Zheng Y, Chen P, et al. The weak correlation between serum vitamin levels and chronic kidney disease in hospitalized patients[J]. BMC Nephrol, 2021, 22(1): 292.
[21] Barreto DV, Barreto FC, Liabeuf S, et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease[J]. Clin J Am Soc Nephrol, 2009, 4(6): 1128-1135.
[22] Pilz S, Tomaschitz A, Friedl C, et al. Vitamin D status and mortality in chronic kidney disease[J]. Nephrol Dial Transplant, 2011, 26(11): 3603-3609.
[23] Guessous I, McClellan W, Kleinbaum D, et al. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population[J]. Clin J Am Soc Nephrol, 2015, 10(7): 1162-1169.
[24] Xu J, Yang J, Chen J, et al. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system[J]. Mol Med Rep, 2017, 16(5): 7432-7438.
[25] Eltablawy N, Ashour H, Rashed LA, et al. Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition[J]. Arch Physiol Biochem, 2018, 124(5): 461-467.
[26] Zhang CJ, Zhao D, Yin X, et al. Effects of 1,25(OH)2D3 on proliferation and apoptosis of human glomerular mesangial cells[J]. Am J Transl Res, 2016, 8(6): 2659-2666.
[27] Santoro D, Caccamo D, Lucisano S, et al. Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system[J]. Biomed Res Int, 2015, 2015: 145828.
[28] Lucisano S, Buemi M, Passantino A, et al. New insights on the role of vitamin D in the progression of renal damage[J]. Kidney Blood Press Res, 2013, 37(6): 667-678.
[29] Zhang YY, Qiu HB, Tian JW. Association between vitamin D and hyperuricemia among adults in the United States[J]. Front Nutr, 2020, 7: 592777.
[30] Faridi KF, Lupton JR, Martin SS, et al. Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk[J]. Arch Med Sci, 2017, 13(4): 732-737.
[31] Peng H, Li H, Li C, et al. Association between vitamin D insufficiency and elevated serum uric acid among middle-aged and elderly Chinese Han women[J]. PLoS One, 2013, 8(4): e61159.
文章导航

/